What are the chances of an action being bifurcated and what are the safeguards?
Personalised medicines and exclusive protection
par Dr Paul England
UPC - Are negative declaratory actions possible?
Seizing IP addresses in the Netherlands as a security for your damages claims in international litigation
par Maarten Rijks
The reform of marketing authorization procedures for medicinal products in the European Union
par Dr. Daniel Tietjen et Sherin Sayed
An overview of the European Commission’s proposals for a Regulation on a unitary SPC and the recast of the SPC Regulation
par Verena Bertram